Department of Medicine, Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Integr Complement Med. 2023 Aug;29(8):468-482. doi: 10.1089/jicm.2022.0532. Epub 2023 Feb 1.
Ginseng has been widely used in fatigue management. However, its efficacy on fatigue remains unclear. This study aimed to assess the efficacy and safety of ginseng and ginseng herbal formulas for fatigue in randomized clinical trials (RCTs). The authors searched PubMed, Embase, Cochrane, Web of Science, and Allied and Complementary Medicine Database (AMED) databases from inception to July 6, 2022. Outcomes included fatigue severity, quality of life (QoL), and adverse events (AEs). Quality of evidence was assessed using the Cochrane Risk of Bias Tool. They pooled all included data and performed subgroup analysis by fatigue type, assessment instrument, and ginseng type. The authors included 19 RCTs. Pooled analyses found no significant reduction in fatigue severity with ginseng versus controls (standardized mean difference [SMD]: -0.36, 95% confidence interval [CI]: -0.82 to 0.11, = 0.13). In subgroup analysis, there was significant fatigue reduction with the ginseng herbal formula (SMD: -0.39, 95% CI: -0.66 to -0.13, = 0.004) and chronic fatigue (CF) (SMD: -0.30, 95% CI: -0.56 to -0.03, = 0.03) compared to controls. Ginseng produced significant reductions in general (i.e., non-disease-specific) fatigue compared to controls (SMD: -0.48, 95% CI: -0.71 to -0.25, < 0.0001). Ginseng was associated with a trend toward QoL improvement ( = 0.05) and did not increase AEs compared with controls. Effect sizes were small. Ginseng herbal formulas improved fatigue severity compared to controls, especially among patients with CF, but with a small effect size. Rigorous RCTs as well as guidelines for standard ginseng usage are needed to further evaluate the effects of ginseng for fatigue and ensure proper use.
人参被广泛用于疲劳管理。然而,其对疲劳的疗效尚不清楚。本研究旨在评估人参和人参草药配方在随机临床试验(RCTs)中治疗疲劳的疗效和安全性。作者检索了 PubMed、Embase、Cochrane、Web of Science 和补充与替代医学数据库(AMED),检索时间截至 2022 年 7 月 6 日。结局指标包括疲劳严重程度、生活质量(QoL)和不良事件(AEs)。使用 Cochrane 偏倚风险工具评估证据质量。他们将所有纳入的数据进行合并,并按疲劳类型、评估工具和人参类型进行亚组分析。作者纳入了 19 项 RCTs。汇总分析发现,与对照组相比,人参对疲劳严重程度没有显著降低(标准化均数差 [SMD]:-0.36,95%置信区间 [CI]:-0.82 至 0.11, = 0.13)。在亚组分析中,与对照组相比,人参草药配方(SMD:-0.39,95% CI:-0.66 至 -0.13, = 0.004)和慢性疲劳(CF)(SMD:-0.30,95% CI:-0.56 至 -0.03, = 0.03)可显著减轻疲劳。与对照组相比,人参可显著减轻一般(即非疾病特异性)疲劳(SMD:-0.48,95% CI:-0.71 至 -0.25, < 0.0001)。与对照组相比,人参与 QoL 改善呈趋势相关( = 0.05),且与对照组相比,不会增加 AEs。效应量较小。人参草药配方与对照组相比可改善疲劳严重程度,尤其是 CF 患者,但效应量较小。需要严格的 RCTs 以及关于人参使用标准的指南,以进一步评估人参治疗疲劳的效果,并确保正确使用。